CompoAtlas

KURKUMA-Pro

Natural health product licensed in Canada

Other names
Bio-CURCUMIN
Licence holder
Provita Nutrition and Health Inc.
NPN or DIN-HM
80062746
Status
Active licence
Licence date
15 July 2015
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Piper nigrum

Source : Piper nigrum - fruit

5 milligrammeNot calculated
(1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione

Source : Curcumine

400 milligrammeNot calculated
Lécithine

Source : Lecithin

100 milligrammeNot calculated
Camellia sinensis

Source : Camellia sinensis - feuille

Extract : Matériel brut sec

Extraction ratio : 80:1

Dry plant equivalent : 4,800 milligramme

Potency : 50 milligramme Catechins

60 milligrammeNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Cellulose microcristalline, Gélatine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Provides antioxidants for the maintenance of good health. Used in Herbal Medicine to help relieve joint inflammation.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80062746

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line